BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27956238)

  • 1. Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32β transgenic mice.
    Jung YY; Katila N; Neupane S; Shadfar S; Ojha U; Bhurtel S; Srivastav S; Son DJ; Park PH; Yoon DY; Hong JT; Choi DY
    Neurochem Int; 2017 Jan; 102():79-88. PubMed ID: 27956238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
    Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor.
    Kang KH; Liou HH; Hour MJ; Liou HC; Fu WM
    Neuropharmacology; 2013 Oct; 73():380-7. PubMed ID: 23800665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion.
    Gao Y; Tang H; Nie K; Zhu R; Gao L; Feng S; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Behav Brain Res; 2019 Aug; 368():111885. PubMed ID: 30959125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.
    Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
    FASEB J; 2002 Sep; 16(11):1474-6. PubMed ID: 12205053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by freshwater clam extract against the neurotoxin MPTP in C57BL/6 mice.
    Hsieh CC; Lin MS; Hua KF; Chen WJ; Lin CC
    Neurosci Lett; 2017 Mar; 642():51-58. PubMed ID: 28126590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation.
    Hwang CJ; Lee HP; Choi DY; Jeong HS; Kim TH; Lee TH; Kim YM; Moon DB; Park SS; Kim SY; Oh KW; Hwang DY; Han SB; Lee HJ; Hong JT
    Oncotarget; 2016 Jul; 7(30):46943-46958. PubMed ID: 27409674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
    Gao L; Díaz-Martín J; Dillmann WH; López-Barneo J
    Neuroscience; 2011 Oct; 193():323-9. PubMed ID: 21782904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.